NO922381L - Stabil integrering av dna i bakteriegenomer - Google Patents

Stabil integrering av dna i bakteriegenomer

Info

Publication number
NO922381L
NO922381L NO92922381A NO922381A NO922381L NO 922381 L NO922381 L NO 922381L NO 92922381 A NO92922381 A NO 92922381A NO 922381 A NO922381 A NO 922381A NO 922381 L NO922381 L NO 922381L
Authority
NO
Norway
Prior art keywords
dna
replication
stable integration
bacterial genomes
origin
Prior art date
Application number
NO92922381A
Other languages
English (en)
Norwegian (no)
Other versions
NO922381D0 (no
Inventor
Steen Troels Joergensen
Per Linaa Joergensen
Boerge Krag Diderichsen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8148687&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO922381(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO922381D0 publication Critical patent/NO922381D0/no
Publication of NO922381L publication Critical patent/NO922381L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO92922381A 1989-12-18 1992-06-17 Stabil integrering av dna i bakteriegenomer NO922381L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK639689A DK639689D0 (da) 1989-12-18 1989-12-18 Indfoering af dna i celler
PCT/DK1990/000332 WO1991009129A1 (en) 1989-12-18 1990-12-18 Stable integration of dna in bacterial genomes

Publications (2)

Publication Number Publication Date
NO922381D0 NO922381D0 (no) 1992-06-17
NO922381L true NO922381L (no) 1992-08-17

Family

ID=8148687

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92922381A NO922381L (no) 1989-12-18 1992-06-17 Stabil integrering av dna i bakteriegenomer

Country Status (11)

Country Link
EP (1) EP0506780B2 (de)
JP (1) JP3162707B2 (de)
AT (1) ATE113077T1 (de)
AU (1) AU643741B2 (de)
CA (1) CA2070676A1 (de)
DE (1) DE69013520T3 (de)
DK (2) DK639689D0 (de)
ES (1) ES2064077T5 (de)
FI (1) FI112502B (de)
NO (1) NO922381L (de)
WO (1) WO1991009129A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2665711B1 (fr) * 1990-08-08 1993-08-13 Centre Nat Rech Scient Integron de corynebacterie, procede de transformation d'une corynebacterie par ledit integron et corynebacterie obtenue.
IL110299A0 (en) 1993-07-15 1994-10-21 Novo Nordisk Entotech Inc Formation of and methods for the production of large bacillus thuringiensis crystals with increased pesticidal activity
AU5001496A (en) * 1995-03-22 1996-10-08 Novo Nordisk A/S Introduction of dna into bacillus strains by conjugation
EP0756007A3 (de) * 1995-06-30 1997-10-29 Ajinomoto Kk Genvermerungsverfahren mit kunstlichen Transposon
EP0878552A1 (de) 1997-05-13 1998-11-18 Erasmus Universiteit Rotterdam Molekularer Nachweis von chromosomalen Veränderungen
AU753578B2 (en) 1997-12-22 2002-10-24 Novozymes A/S Carbohydrate oxidase and use thereof in baking
AU3516899A (en) 1998-05-04 1999-11-23 Dako A/S Method and probes for the detection of chromosome aberrations
EP2284272B1 (de) 1998-06-10 2014-08-13 Novozymes A/S Mannanasen
JP3958884B2 (ja) 1998-09-11 2007-08-15 株式会社林原生物化学研究所 非還元性糖質生成酵素及びトレハロース遊離酵素ならびに該酵素を用いる糖質の製造方法
AU6188599A (en) 1998-10-26 2000-05-15 Novozymes A/S Constructing and screening a dna library of interest in filamentous fungal cells
JP2004501651A (ja) 2000-06-23 2004-01-22 ノボザイムス　アクティーゼルスカブ 遺伝子の安定した染色体多コピー組み込みのための方法
JP4242761B2 (ja) 2001-06-06 2009-03-25 ノボザイムス アクティーゼルスカブ エンド−β−１，４−グルカナーゼ
EP2213745A1 (de) 2002-04-10 2010-08-04 Novozymes A/S Verbesserte Bacillus-Wirtszelle
EP1995319B1 (de) 2002-04-10 2011-08-31 Novozymes A/S Mutierte Bacillus licheniformis Wirtszelle
WO2003095658A1 (en) * 2002-05-07 2003-11-20 Novozymes A/S Homologous recombination into bacterium for the generation of polynucleotide libraries
US20060035800A1 (en) 2002-12-11 2006-02-16 Novozymes A/S Detergent composition
DK1694846T3 (en) 2003-12-10 2014-11-17 Novozymes As Cell with enhanced secretion mediated by MrgA protein or a homolog
CN101006174B (zh) 2004-06-21 2010-05-26 诺维信公司 以相同取向稳定保持的至少两个orf的多拷贝
EP2089516B1 (de) 2006-11-29 2011-11-16 Novozymes Inc. Verfahren zur verbesserten einführung von dna in bakterienzellen
WO2008140615A2 (en) 2006-12-21 2008-11-20 Novozymes, Inc. Modified messenger rna stabilizing sequences for expressing genes in bacterial cells
US20120329090A1 (en) 2009-12-21 2012-12-27 Novozymes A/S Methods for Producing Heterologous Polypeptides in Thiol-Disulfide Oxidoreductase-Deficient Bacterial Mutant Cells
CN109804072A (zh) 2016-10-25 2019-05-24 诺维信公司 地衣芽孢杆菌中flp介导的基因组整合
EP3655422B1 (de) 2017-07-21 2023-03-29 Basf Se Promotor zur heterologen expression
CN110892066A (zh) 2017-07-21 2020-03-17 巴斯夫欧洲公司 转化细菌细胞的方法
EP3707252A1 (de) 2017-11-10 2020-09-16 Novozymes A/S Temperaturempfindliches cas9-protein
US20210017544A1 (en) 2017-12-22 2021-01-21 Novozymes A/S Counter-Selection by Inhibition of Conditionally Essential Genes
WO2020156903A1 (en) 2019-01-30 2020-08-06 Novozymes A/S Cognate foldase co-expression
WO2020169563A1 (en) 2019-02-20 2020-08-27 Basf Se Industrial fermentation process for bacillus using defined medium and magnesium feed
US20220186234A1 (en) 2019-02-20 2022-06-16 Basf Se Industrial Fermentation Process for Bacillus Using Defined Medium and Trace Element Feed
WO2020182552A1 (en) 2019-03-08 2020-09-17 Novozymes A/S Means and methods for improving protease expression
WO2020229191A1 (en) 2019-05-15 2020-11-19 Novozymes A/S Temperature-sensitive rna-guided endonuclease
EP3990629A1 (de) 2019-06-25 2022-05-04 Novozymes A/S Gegenauswahl durch hemmung von bedingt essenziellen genen
EP3994273A1 (de) 2019-07-02 2022-05-11 Basf Se Verfahren zur herstellung eines fermentationsmediums
EP4189104A1 (de) 2020-07-28 2023-06-07 Basf Se Industrielles fermentationsverfahren für bacillus unter verwendung von partieller ernte
MX2023001272A (es) 2020-07-28 2023-03-03 Basf Se Proceso de fermentacion industrial para bacillus mediante el uso de cambio de temperatura.
KR20230042509A (ko) 2020-07-28 2023-03-28 바스프 에스이 공급 속도 이동을 이용한 바실러스의 산업적 발효 방법
EP4225779A2 (de) 2020-10-07 2023-08-16 Basf Se Bacilluszelle mit reduzierter lipase- und/oder esteraseseitenaktivität
US20240294894A1 (en) 2021-06-24 2024-09-05 Basf Se Improved bacillus host cell with altered rema/remb protein
EP4359423A1 (de) 2021-06-24 2024-05-01 Basf Se Bacillus licheniformis-wirtszelle zur herstellung einer verbindung von interesse mit erhöhter reinheit
EP4370534A1 (de) 2021-07-13 2024-05-22 Novozymes A/S Rekombinante cutinase-expression
WO2023247514A1 (en) 2022-06-22 2023-12-28 Novozymes A/S Recombinant mannanase expression
US20260062690A1 (en) 2022-08-02 2026-03-05 Basf Se Stabilized protein production process using bacillus host cells
WO2025132815A1 (en) 2023-12-20 2025-06-26 Novozymes A/S Novel cas nucleases and polynucleotides encoding the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4631257A (en) * 1978-12-26 1986-12-23 Cetus Corporation Stable high copy number plasmids
US4401761A (en) * 1981-01-26 1983-08-30 The Upjohn Company Process for stabilizing plasmids by deletion of DNA

Also Published As

Publication number Publication date
FI922812A0 (fi) 1992-06-17
JP3162707B2 (ja) 2001-05-08
WO1991009129A1 (en) 1991-06-27
AU643741B2 (en) 1993-11-25
DE69013520D1 (de) 1994-11-24
FI112502B (fi) 2003-12-15
DE69013520T3 (de) 2004-09-23
DE69013520T2 (de) 1995-05-04
EP0506780A1 (de) 1992-10-07
ES2064077T3 (es) 1995-01-16
EP0506780B2 (de) 2004-01-02
FI922812L (fi) 1992-06-17
CA2070676A1 (en) 1991-06-19
DK0506780T4 (da) 2004-04-26
DK0506780T3 (da) 1995-04-18
ES2064077T5 (es) 2004-09-01
EP0506780B1 (de) 1994-10-19
JPH05502162A (ja) 1993-04-22
ATE113077T1 (de) 1994-11-15
DK639689D0 (da) 1989-12-18
AU7031291A (en) 1991-07-18
NO922381D0 (no) 1992-06-17

Similar Documents

Publication Publication Date Title
NO922381D0 (no) Stabil integrering av dna i bakterielle genomer
TR200401186T4 (tr) Rekombinant bir RNA-virüs oluşumunu yönlendirebilen nükleik asit sekansları içerikli suni kromozom yapıları.
HUP9900050A1 (hu) Rekombináns adenovírusok, és felhasználásuk adeno-asszociált vírusok (AAV) előállítására, komplementáló sejtvonalak, és az illető adenovírusokat tartalmazó gyógyszerkészítmények
CA2064092A1 (en) Efficient directional genetic cloning system
ATE239036T1 (de) Rekombinantes core-streptavidin
SE8603145D0 (sv) Forfarande for framstellning av interferon-beta
Xu et al. The complete mitochondrial DNA sequence of the white rhinoceros, Ceratotherium simum, and comparison with the mtDNA sequence of the Indian rhinoceros, Rhinoceros unicornis
FI875082A0 (fi) Dna-sekvensser deriverade fraon genom av papillomavirus, deras anvaendning foer in vitro diagnostiska aendamaol; samt framstaellning av antigeniska kompositioner.
JP2002519061A5 (de)
DK1792982T3 (da) Codon-optimeret phosphatase og ekspression heraf i gær
DK0727483T3 (da) Retrovirus fra HIV-gruppen og dens anvendelse
DE69318716D1 (de) Anti-Katze Immundefiziensvirus (FIV) Impfstoffe
WO1995005460A3 (en) Feline immunodeficiency virus isolate ncsu 1
AU3929589A (en) Human papilloma virus type 57, the dna thereof and the proteins encoded thereby
DK76688D0 (da) Vaccine indeholdende f-proteinet fra aids-virus
JPS6486874A (en) Cloned dna containing transcription promoting factor s-ii, its fragment, preparation thereof, plasmid containing said cloned dna or fragment and method for diagnosing viral disease and cancer using said cloned dna or fragment
Lorenz et al. Sequencing of RAPD fragments amplified from the genome of the prokaryote Prochlorococcus marinus (Prochlorophyta)
Woloszyn et al. Nucleotide sequence of the bovine enteric coronavirus BECV F15 mRNA 5 and mRNA 6 unique regions
DE3751114D1 (de) Dmd-sonden.
DE69839269D1 (de) Infektiöse vektoren und pflanzenklone, die sich von turnip mosaikvirus herleiten
Tompkins et al. Feline immunodeficiency virus isolate NCSU1LB
NO20032081L (no) Fremgangsmåte for fremstilling av 4-(17<alfa>-alkoksymetyl- 17<beta>-substituert-3-oksoöstra-4,9-dien-11<beta>-yl)benzaldehyd-(1E)-oksim-derivater
EP0828006A3 (de) Verwendung von cis- und/oder trans-Elementen, um die Wirksamkeit der Transduktion, Integration und/oder Transgene-Expression von Parvoviren zu steigen
NO941544L (no) Rekombinant kjerne-streptavidin